PLoS ONE (Jan 2022)

Assessment and counseling to get the best efficiency and effectiveness of the assistive technology (MATCH): Study protocol

  • Thais Pousada García,
  • Betania Groba Gonzalez,
  • Laura Nieto-Riveiro,
  • Nereida Canosa Domínguez,
  • Saturnino Maldonado-Bascón,
  • Roberto J. López-Sastre,
  • Soraya Pacheco DaCosta,
  • Isabel González-Gómez,
  • Alberto J. Molina-Cantero,
  • Javier Pereira Loureiro

Journal volume & issue
Vol. 17, no. 3

Abstract

Read online

Aims To determine the psychosocial impact of assistive technology(AT) based on robotics and artificial intelligence in the life of people with disabilities. Background The best match between any person with disabilities and its AT only can be gotten through a complete assessment and monitoring of his/her needs, abilities, priorities, difficulties and limitations. Without this analysis, it’s possible that the device won’t meet the individual’s expectations. Therefore, it is important that any project focused on the development of innovating AT for people with disabilities includes the perspective of outcome measures as an important phase of the research. In this sense, the integration of the assessment, implementation process and outcome measures is crucial to guarantee the transferability for the project findings and to get the perspective from the final user. Methods Pilot study, with prospective, longitudinal and analytical cohort. The study lasts from July 2020 until April 2023. The sample is formed by people with disabilities, ages from 2–21, that will participate from the first stage of the process (initial assessment of their abilities and needs) to the final application of outcome measures instruments (with a complete implication during the test of technology). Discussion Only with the active participation of the person is possible to carry out a user-centered approach. This fact will allow us to define and generate technological solutions that really adjust to the expectations, needs and priorities of the people with disabilities, avoiding the AT from being abandoned, with the consequent health and social spending. Trial registration Clinical Trials ID: NCT04723784; https://clinicaltrials.gov/.